FDA :Opdivo® as the First New Medication for Certain Patients with Previously Treated Small Cell Lung Cancer Monday August 20th, 2018By Tokio X'press FDA, Pharmaceutical ONO
Will The New Generic EpiPen Be Cheaper? Friday August 17th, 2018By Tokio X'press FDA, Pharmaceutical Will The New Generic EpiPen
FDA: Eisai ‘s “Rembima” approved as a hepatocellular cancer drug Saturday August 18th, 2018By Tokio X'press Cancer, FDA, Pharmaceutical
China’s drug regulator launches nationwide investigation into vaccine producers Tuesday July 31st, 2018By Tokio X'press Vaccine, Pharmaceutical China's drug regulator into vaccine producers
23andMe Is Sharing Its 5 Million Clients’ Genetic Data with Drug Giant GlaxoSmithKline Friday July 27th, 2018By Tokio X'press Drugs, Pharmaceutical 23andMe